Yes, absolutely.
I think the ongoing Patented Medicine Prices Review Board regulations are a perfect example of this. The department has come out with regulations. It says that the objective is to lower drug prices. It presents the analysis that underpins that. It went to industry and asked for industry feedback. Industry says they think there will be negative impacts on employment, innovation and investment. They think there will be a lot of problems with what this will mean for the pharmaceutical industry in Canada.
The output from the department is that the original analysis was right. Somewhere along the way there's somebody who's not being told that they need to sit down with industry and try to come together to determine what the real impacts of this will be and not pretend that there won't be these impacts just because we have the social objective of trying to lower drug prices.
That's a perfect example of why embedding innovation and economic growth mandates will empower, encourage and require those officials to actually sit down and determine the true costs of some of these things.